Journal of Clinical Immunology

• 

  Publication Venue For

  • Childhood Hodgkin Lymphoma: Think DADA2..  39:26-29. 2019
  • Warts and DADA2: a Mere Coincidence?.  38:836-843. 2018
  • ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome..  38:484-493. 2018
  • Low Serum IgE Is a Sensitive and Specific Marker for Common Variable Immunodeficiency (CVID). 2018
  • Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism..  37:746-750. 2017
  • Two Sides of the Same Coin: Pediatric-Onset and Adult-Onset Common Variable Immune Deficiency..  37:592-602. 2017
  • Flebogamma(®) 5 % DIF Intravenous Immunoglobulin for Replacement Therapy in Children with Primary Immunodeficiency Diseases..  36:583-589. 2016
  • Dominant Splice Site Mutations in PIK3R1 Cause Hyper IgM Syndrome, Lymphadenopathy and Short Stature..  36:462-471. 2016
  • Hyper IgM Syndrome: a Report from the USIDNET Registry.  36:490-501. 2016
  • Deficiency of Adenosine Deaminase 2 Causes Antibody Deficiency..  36:179-186. 2016
  • Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience..  35:624-637. 2015
  • Disseminated Mycobacterium kansasii disease in complete DiGeorge syndrome..  35:435-438. 2015
  • Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning..  35:384-398. 2015
  • ICON: the early diagnosis of congenital immunodeficiencies..  34:398-424. 2014
  • Psychrobacter immobilis septicemia in a boy with X-linked chronic granulomatous disease and fulminant hepatic failure..  34:39-41. 2014
  • The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901..  33:1156-1164. 2013
  • Bioavailability of IgG administered by the subcutaneous route..  33:984-990. 2013
  • KRECs BUT NOT TRECs IDENTIFY PATIENTS WITH DELAYED- ONSET ADENOSINE DEAMINASE (ADA) DEFICIENCY IN NEONATAL SCREENING.  33:673-673. 2013
  • RESPONSE TO BACTERIOPHAGE Phi chi 174 IN CHILDREN WITH PARTIAL DIGEORGE ANOMALY AND IN CHILDREN WITH COMPLETE DIGEORGE ANOMALY AFTER CULTURED POSTNATAL ALLOGENEIC THYMUS TRANSPLANTATION.  33:679-680. 2013
  • THYMUS TRANSPLANTATION IN A THREE YEAR OLD CHILD WHO DID NOT DEVELOP SUFFICIENT NAIVE CD4 T CELLS AFTER PARENTAL BONE MARROW STEM CELL TRANSPLANTATION.  33:676-676. 2013
  • Post-transplantation B cell function in different molecular types of SCID.  33:96-110. 2013
  • Post-transplantation B cell function in different molecular types of SCID..  33:96-110. 2013
  • The natural history of children with severe combined immunodeficiency: Baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.  33:1156-1164. 2013
  • Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency..  32:1141-1144. 2012
  • Post-Transplantation B Cell Function in Different Molecular Types of SCID.  1-15. 2012
  • Tolerability of a new 10% liquid immunoglobulin for intravenous use, Privigen, at different infusion rates..  30:442-448. 2010
  • The Effect of Natural Killer Cell Killer Ig-Like Receptor Alloreactivity on the Outcome of Bone Marrow Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID).  27:659-659. 2007
  • Population prevalence of diagnosed primary immunodeficiency diseases in the United States..  27:497-502. 2007
  • Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss..  27:53-68. 2007
  • The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID)..  27:109-116. 2007
  • Naïve T cells are maintained in the periphery during the first 3 months of acute HIV-1 infection: implications for analysis of thymus function..  25:462-472. 2005
  • Expression of the CD7 ligand K-12 in human thymic epithelial cells: regulation by IFN-gamma..  25:41-49. 2005
  • Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients..  24:449-461. 2004
  • Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose..  20:434-444. 2000
  • Immunochemical properties of anti-Gal alpha 1-3Gal antibodies after sensitization with xenogeneic tissues..  19:116-126. 1999
  • Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion..  19:135-142. 1999
  • Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components..  18:81-88. 1998
  • Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development..  17:311-321. 1997
  • Normalization of the peripheral blood T cell receptor V beta repertoire after cultured postnatal human thymic transplantation in DiGeorge syndrome..  17:167-175. 1997
  • Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases..  17:21-28. 1997
  • Somatic diversification of antibody responses..  16:1-11. 1996
  • Transplant-associated autoimmune mechanisms in human hepatitis C virus infection..  16:60-70. 1996
  • Animal models for complement deficiencies.  15. 1995
  • Animal models for complement deficiencies..  15:113S-121S. 1995
  • Expression of CD44 variants in human inflammatory synovitis..  15:300-311. 1995
  • Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes..  15:80-92. 1995
  • Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160.  12:429-439. 1992
  • Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network..  12:429-439. 1992
  • Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures..  12:353-361. 1992
  • In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice..  12:311-324. 1992
  • Increase in TCR gamma delta T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis..  12:130-138. 1992
  • Pairing of VK and VK gene families in self-reactive antibodies..  10:223-236. 1990
  • Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency..  10:106-114. 1990
  • Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry..  10:19-27. 1990
  • Enhanced neutrophil chemiluminescence in familial Mediterranean fever..  8:148-156. 1988
  • Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients..  7:389-399. 1987
  • Ontogeny of the human thymus during fetal development..  7:81-97. 1987
  • Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies..  7:8-15. 1987
  • Appearance of multiple benign paraproteins during early engraftment of soy lectin T cell-depleted haploidentical bone marrow cells in severe combined immunodeficiency.  6:161-169. 1986
  • The role of receptors for complement in the induction of polyclonal B-cell proliferation and differentiation..  6:65-73. 1986
  • Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and nonlinkage to the HLA system..  3:90-99. 1983
  • Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problem.  2. 1982
  • Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: Inadequacy of current dosage practices and approaches to the problem.  2:15S-21S. 1982
  • Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem..  2:15S-21S. 1982
  • The C1 esterase inhibitor and hereditary angioedema..  2:65-68. 1982
  • Immunologic studies before and after splenectomy in a patient with the Wiskott-Aldrich syndrome..  1:13-19. 1981
  • Hyper IgM Syndrome: a Report from the USIDNET Registry. 2016
  • HSCT Rescues the Immunological and Vascular Phenotype of ADA2-Deficiency 2014
  • LATE-ONSET PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY WITH SPASTIC PARAPLEGIA 2014
  • Dna Ligase IV Deficiency With Novel Compound Heterozygous Mutations 2014
  • Human Syndromes of Immune Deficiency and Dysregulation are Characterized by Distinct Defects in T-Cell Receptor Repertoire Development 2014
  • Impulse Oscillometry (IOS) Reveals Increased Pulmonary Impedence in Children with Adenosine Deaminase-Deficient Severe Combined Immunodeficiency (ADA-SCID) 2014
  • SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY: EVIDENCE FROM THREE CASE REPORTS 2013
  • MUTATION SCREENING IN STAT1, CARD9 AND PKC-DELTA IN PATIENTS WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS 2012
  • US RESULTS OF GENE THERAPY FOR ADENOSINE DEAMINASE DEFICIENCY 2012
  • Systemic Effects of PEG-ADA Withdrawal with or Without Chemotherapy (CHTX) and Cytotherapy (CTX) in Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID) 2012